AS IT STANDS | Roman Floresca
It’s been well over one year now and little by little we can see the light at the end of the tunnel. But it is now more than ever that we have to be more careful and have to be vigilant about the Covid 19 pandemic.
Only a few days ago a Filipino seaman was found on the beach of a village in Vanuatu. Authorities confirmed after several tests that the body was infected with coronavirus.
That may be an isolated case, but it is precisely such incidents that we have to look out for so that we won’t stumble so close to the end.
Anyway, we can heave a sigh of relief by taking a spoonful of virgin coconut oil (VCO) at least once a day. After several trials, VCO is now being pushed as alternative treatment for mild symptoms of Covid-19.
With coronavirus cases still rising and hospital occupancy rates rising, and vaccines in short supply, an abundant, locally-produced, anti-viral, anti-bacterial food supplement is now being pushed for patients with mild symptoms.
Karlo Nograles, the co-chairman of the Inter-Agency Task Force for the Management of Emerging Infectious Diseases (IATF-EID), recently started the distribution of VCO boxes to hospitals in Metro Manila.
As of last week, patients in two hospitals in Metro Manila have agreed to take VCO to complement their Covid-19 treatment.
“It’s about time we explore potential alternative treatments against Covid-19, alternatives that are backed by science and do not pose a threat to the health of Covid-positive individuals,” Nograles said.
VCO Philippines donated boxes of free VCO from its member manufacturers.
Marco Reyes of VCO Philippines said their members are aware that “we all have to contribute in our country’s battle against Covid.”
“What is good here, we are not only helping our countrymen afflicted with Covid-19. We are also helping our coconut producers, farmers, and workers,” he said.
Data show that only 30 percent of the current capacity of VCO is being utilized. The market consumes an estimated 470 metric tons of VCO.
With renewed public interest, VCO manufacturers are seeing a 20 percent growth in demand this year.
Meanwhile, clinical trials for herbal medicines Lagundi and Tawa-Tawa are continuing with the results out very soon. Dr. Jaime Montoya, executive director of DOST-Philippine Council for Health Research and Development, said the two have to go through a couple of study phases — to determine the appropriate dose and to check for effectiveness.